<DOC>
	<DOCNO>NCT01334008</DOCNO>
	<brief_summary>Circulating tumor DNA detection quantification patient metastatic choroidal melanoma .</brief_summary>
	<brief_title>Study Circulating Tumoral DNA Metastatic Choroidal Melanoma</brief_title>
	<detailed_description>Technique development : In first step , different available technique evaluate specificity sensibility use serial dilution cell line without GNAQ mutation . Validation : The tumor DNA detection rate estimate metastatic uveal patient 's blood . The investigator study 40 patient obtain least 15 patient bear GNAQ mutation primitive tumor metastasis . With 15 patient , investigator determinate sensitive technique best cost/efficiency ratio .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Age &gt; = 18 year . Patient metastatic choroidal melanoma . Patient tumor metastasis available GNAQ ( Guanine nucleotide blind protein ) status characterization . Patient able stand blood collection . Signed write informed consent approve competent authority ethic committee . Patient without social protection/insurance . Current pregnancy lactation . All social , medical , psychological , situation make study impossible . Person deprive liberty .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Circulating tumor DNA</keyword>
	<keyword>Choroidal Melanoma</keyword>
</DOC>